Tonix Pharmaceuticals Holding Corp (TNXP)

[$Moneypenny$]

It's an extension of fibro study, from the pr about regular best fit data a few weeks back:

"Tonix also today announced an update on Study F203, an ongoing, 12-month, open-label extension study of TNX-102 SL taken daily at bedtime. Patients who successfully completed the BESTFIT study could optionally enroll into this open-label study. Of the 174 patients who completed BESTFIT, 158 (91%) enrolled into Study F203. Of these 158 patients, 108 (68%) completed at least six months in Study F203. This study is expected to complete in August 2015."